The Food and Drugs Authority (FDA) has withdrawn the marketing authorisation of Omama Herbal Mixture after laboratory tests confirmed that the product was adulterated with prescription-only medicines.
A statement signed by the Acting Chief Executive Officer, Professor Kwabena Frimpong-Manso Opuni, explained that the action followed a market surveillance exercise conducted in collaboration with the Ghana Police Service.
Tests showed the mixture contained Diazepam, Metronidazole, Paracetamol and Niacinamide — conventional drugs prohibited in approved herbal products.
The FDA said Omama Herbal Mixture was registered solely as a herbal treatment for malaria and loss of appetite, but the unauthorised addition of those substances posed serious health dangers to consumers.
“The medicines found in Omama Herbal Mixture are dangerous when taken without prescription or advice from a qualified health professional,” the statement cautioned.
The Authority urged the public to immediately stop using or buying the product and noted that it is working with the manufacturer, Omama Herbal Group Limited, to recall affected batches for safe disposal.
It further revealed that both regulatory and criminal actions have begun against those involved in the adulteration, reaffirming its commitment to protecting public health.
“The FDA will not relent in its effort to ensure public health and safety,” the statement stressed.
The public has been advised to report anyone found selling the product to the nearest FDA office.
